Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Cyclosporin doesn't stop hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Sinapic acid may help hair growth by activating a specific cell pathway.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.